144 related articles for article (PubMed ID: 10843688)
1. Primary structure and functional characterization of a soluble, alternatively spliced form of B7-1.
Faas SJ; Giannoni MA; Mickle AP; Kiesecker CL; Reed DJ; Wu D; Fodor WL; Mueller JP; Matis LA; Rother RP
J Immunol; 2000 Jun; 164(12):6340-8. PubMed ID: 10843688
[TBL] [Abstract][Full Text] [Related]
2. Blockade of CD28-B7, but not CD40-CD154, prevents costimulation of allogeneic porcine and xenogeneic human anti-porcine T cell responses.
Lee RS; Yamada K; Womer KL; Pillsbury EP; Allison KS; Marolewski AE; Geng D; Thall AD; Arn JS; Sachs DH; Sayegh MH; Madsen JC
J Immunol; 2000 Mar; 164(6):3434-44. PubMed ID: 10706740
[TBL] [Abstract][Full Text] [Related]
3. Mutational analysis and an alternatively spliced product of B7 defines its CD28/CTLA4-binding site on immunoglobulin C-like domain.
Guo Y; Wu Y; Zhao M; Kong XP; Liu Y
J Exp Med; 1995 Apr; 181(4):1345-55. PubMed ID: 7535334
[TBL] [Abstract][Full Text] [Related]
4. Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation.
Freeman GJ; Gribben JG; Boussiotis VA; Ng JW; Restivo VA; Lombard LA; Gray GS; Nadler LM
Science; 1993 Nov; 262(5135):909-11. PubMed ID: 7694363
[TBL] [Abstract][Full Text] [Related]
5. Costimulation of T-cell activation and virus production by B7 antigen on activated CD4+ T cells from human immunodeficiency virus type 1-infected donors.
Haffar OK; Smithgall MD; Bradshaw J; Brady B; Damle NK; Linsley PS
Proc Natl Acad Sci U S A; 1993 Dec; 90(23):11094-8. PubMed ID: 7504294
[TBL] [Abstract][Full Text] [Related]
6. Uncovering of functional alternative CTLA-4 counter-receptor in B7-deficient mice.
Freeman GJ; Borriello F; Hodes RJ; Reiser H; Hathcock KS; Laszlo G; McKnight AJ; Kim J; Du L; Lombard DB
Science; 1993 Nov; 262(5135):907-9. PubMed ID: 7694362
[TBL] [Abstract][Full Text] [Related]
7. The IgV domain of human B7-2 (CD86) is sufficient to co-stimulate T lymphocytes and induce cytokine secretion.
Rennert P; Furlong K; Jellis C; Greenfield E; Freeman GJ; Ueda Y; Levine B; June CH; Gray GS
Int Immunol; 1997 Jun; 9(6):805-13. PubMed ID: 9199963
[TBL] [Abstract][Full Text] [Related]
8. Porcine CTLA4-Ig lacks a MYPPPY motif, binds inefficiently to human B7 and specifically suppresses human CD4+ T cell responses costimulated by pig but not human B7.
Vaughan AN; Malde P; Rogers NJ; Jackson IM; Lechler RI; Dorling A
J Immunol; 2000 Sep; 165(6):3175-81. PubMed ID: 10975832
[TBL] [Abstract][Full Text] [Related]
9. CTLA-4 (CD152) can inhibit T cell activation by two different mechanisms depending on its level of cell surface expression.
Carreno BM; Bennett F; Chau TA; Ling V; Luxenberg D; Jussif J; Baroja ML; Madrenas J
J Immunol; 2000 Aug; 165(3):1352-6. PubMed ID: 10903737
[TBL] [Abstract][Full Text] [Related]
10. B7-CD28 interaction is a late acting co-stimulatory signal for human T cell responses.
Zhang YQ; Joost van Neerven RJ; Van Gool SW; Coorevits L; de Boer M; Ceuppens JL
Int Immunol; 1997 Aug; 9(8):1095-102. PubMed ID: 9263006
[TBL] [Abstract][Full Text] [Related]
11. Chimeric co-stimulatory molecules that selectively act through CD28 or CTLA-4 on human T cells.
Lazetic S; Leong SR; Chang JC; Ong R; Dawes G; Punnonen J
J Biol Chem; 2002 Oct; 277(41):38660-8. PubMed ID: 12167647
[TBL] [Abstract][Full Text] [Related]
12. Crystallization and functional analysis of a soluble deglycosylated form of the human costimulatory molecule B7-1.
Davis SJ; Ikemizu S; Collins AV; Fennelly JA; Harlos K; Jones EY; Stuart DI
Acta Crystallogr D Biol Crystallogr; 2001 Apr; 57(Pt 4):605-8. PubMed ID: 11264596
[TBL] [Abstract][Full Text] [Related]
13. Identification of residues in the V domain of CD80 (B7-1) implicated in functional interactions with CD28 and CTLA4.
Fargeas CA; Truneh A; Reddy M; Hurle M; Sweet R; Sékaly RP
J Exp Med; 1995 Sep; 182(3):667-75. PubMed ID: 7544393
[TBL] [Abstract][Full Text] [Related]
14. Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors.
Linsley PS; Greene JL; Brady W; Bajorath J; Ledbetter JA; Peach R
Immunity; 1994 Dec; 1(9):793-801. PubMed ID: 7534620
[TBL] [Abstract][Full Text] [Related]
15. Synergy between cyclosporin A and a monoclonal antibody to B7 in blocking alloantigen-induced T-cell activation.
Van Gool SW; Ceuppens JL; Walter H; de Boer M
Blood; 1994 Jan; 83(1):176-83. PubMed ID: 7506079
[TBL] [Abstract][Full Text] [Related]
16. Murine B7-2, an alternative CTLA4 counter-receptor that costimulates T cell proliferation and interleukin 2 production.
Freeman GJ; Borriello F; Hodes RJ; Reiser H; Gribben JG; Ng JW; Kim J; Goldberg JM; Hathcock K; Laszlo G
J Exp Med; 1993 Dec; 178(6):2185-92. PubMed ID: 7504059
[TBL] [Abstract][Full Text] [Related]
17. The cytoplasmic domain of CD28 is both necessary and sufficient for costimulation of interleukin-2 secretion and association with phosphatidylinositol 3'-kinase.
Stein PH; Fraser JD; Weiss A
Mol Cell Biol; 1994 May; 14(5):3392-402. PubMed ID: 8164687
[TBL] [Abstract][Full Text] [Related]
18. Structure of murine CTLA-4 and its role in modulating T cell responsiveness.
Ostrov DA; Shi W; Schwartz JC; Almo SC; Nathenson SG
Science; 2000 Oct; 290(5492):816-9. PubMed ID: 11052947
[TBL] [Abstract][Full Text] [Related]
19. Detection of a soluble form of B7-1 (CD80) in synovial fluid from patients with arthritis using monoclonal antibodies against distinct epitopes of human B7-1.
McHugh RS; Ratnoff WD; Gilmartin R; Sell KW; Selvaraj P
Clin Immunol Immunopathol; 1998 Apr; 87(1):50-9. PubMed ID: 9576010
[TBL] [Abstract][Full Text] [Related]
20. Functional expression of a costimulatory B7.2 (CD86) protein on human salivary gland epithelial cells that interacts with the CD28 receptor, but has reduced binding to CTLA4.
Kapsogeorgou EK; Moutsopoulos HM; Manoussakis MN
J Immunol; 2001 Mar; 166(5):3107-13. PubMed ID: 11207262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
